Drug-induced anaphylaxis: Case/non-case study based on an Italian pharmacovigilance database

Drug Safety

Volumn 28, Issue 6, 2005, Pages 547-556

  Leone, Roberto ^a,d   Conforti, Anita ^a   Venegoni, Mauro ^b   Motola, Domenico ^c   Moretti, Ugo ^a   Meneghelli, Ilaria ^a   Cocci, Alfredo ^b   Cellini, Giulia Sangiorgi ^c   Scotto, Stefania ^b   Montanaro, Nicola ^c   Velo, Giampaolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Lombardy Centre of Pharmacovigilance   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Clinical Pharmacology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANALGESIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CELECOXIB; CEPHALOSPORIN DERIVATIVE; CINOXACIN; DICLOFENAC; DIPYRONE; GLYCOPEPTIDE; IBUPROFEN; IOMEPROL; IOPROMIDE; KETOPROFEN; KETOROLAC; LEVOFLOXACIN; MACROLIDE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PIPERACILLIN; PIROXICAM; PROPYPHENAZONE; QUINOLONE DERIVATIVE; ROFECOXIB; TEICOPLANIN; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

ANAPHYLAXIS; ARTICLE; CALCULATION; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DATA BASE; FEMALE; GASTROINTESTINAL TRACT; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROBABILITY; RESPIRATORY SYSTEM; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANAPHYLAXIS; ANTI-BACTERIAL AGENTS; ANTIPYRINE; CASE-CONTROL STUDIES; CONTRAST MEDIA; DATABASES, FACTUAL; DICLOFENAC; DIPYRONE; FEMALE; HUMANS; INPATIENTS; ITALY; MALE; MIDDLE AGED; OUTPATIENTS; PHARMACOEPIDEMIOLOGY; POLYGELINE; TIME FACTORS;

EID: 22344452501     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200528060-00006     Document Type: Article

References (74)

1. Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med 1991; 324: 1785-90
2. Ewan PW. Anaphylaxis. BMJ 1998; 316: 1442-5
3. O'Hollaren MT. Anaphylaxis: new clues to clinical patterns and optimum treatment. Medscape Allergy & Clinical Immunology 2002; 2 (2) [online]. Available from URL: http://www.med-scape.com/viewarticle/439721 [Accessed 2005 Apr 21]
4. Anderson JA. Allergic reactions to drugs and biological agents. JAMA 1992; 268: 2845-57
5. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 2001; 161: 15-21
6. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002; 110: 341-8
7. Lieberman PL. Anaphylaxis. Medscape General Medicine 1999; 1 (1) [online]. Available from URL: http://www.med-scape.com/viewarticle/408706 [Accessed 2005 Apr 21]
8. Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000; 320: 1441
9. Brown AFT, McKinnon D. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108: 861-6
10. International Collaborative Study of Severe Anaphylaxis. An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. Epidemiology 1998; 9: 141-6
11. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986; 78: 76-83
12. Yocum MW, Butterfield LH, Klein JS, et al. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999; 104: 452-6
13. Haddi E, Cherpin D, Taffareau M, et al. Atopy and systemic reactions to drugs. Allergy 1990; 45: 236-9
14. Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 2001; 31: 1571-6
15. Drain KL, Volcheck GW. Preventing and managing drug-induced anaphylaxis. Drug Saf 2001; 24: 843-53
16. Weiss WE, Adkinson NF. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy 1988; 18: 515-40
17. Kaufman DW, Kelly JP. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 2003; 12: 195-202
18. Wang D-Y, Forslund C, Persson U, et al. Drug-attributed anaphylaxis. Pharmacoepidemiol Drug Saf 1998; 7: 269-74
19. Lenler-Petersen P, Hansen D, Andersen M, et al. Drug-related anaphylactic shock in Denmark 1968-1990: a study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol 1995; 48: 1185-8
20. Van der Klauw MM, Wilson JHP, Stricker BH. Drug-associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature. Clin Exp Allergy 1996; 26: 1355-63
21. van Puijenbroek EP, Bate A, Leufkens GM, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 1: 3-10
22. Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 2003; 57: 127-34
23. Meyboom RHB, Hekster YA, Egberts ACG, et al. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 17: 374-89
24. van Puijenbroek EP, Egberts ACG, Meyboom RHB, et al. Different risks for NSAID induced anaphylaxis. Ann Pharmacother 2002; 36: 24-9
25. Hauben M, Zhou X. Quantitative methods in pharmacovigilance. Drug Saf 2003; 26: 159-86
26. Van der Heijden PGM, van Puijenbroek EP, van Buuren S, et al. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratio. Stat Med 2002; 21: 2027-44
27. Moore N, Kreft-Jais C, Haramburu F, et al. Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol 1997; 44: 513-8
28. Vaccheri A, Bjerrum L, Resi D, et al. Antibiotic prescribing in general practice: striking differences between Italy (Ravenna) and Denmark (Funen). J Antimicrob Chemother 2002; 50: 89-97
29. Bergman U, Andersen M, Vaccheri A, et al. Deviation from evidence-based prescribing of non-steroidal anti-inflammatory drugs in three European Regions. Eur J Clin Pharmacol 2000; 56: 269-72
30. Magrini N, Einarson T, Vaccheri A, et al. Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna region), Norway and Sweden. Eur J Clin Pharmacol 1997; 53: 185-9
31. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-3
32. Assem E-SK. Drug allergy and tests for its detection. In: Davies DM, Ferner RE, de Glanville H, editors. Davies's textbook of adverse drug reactions. 5th ed. London: Chapman & Hall Medical, 1998: 791-815
33. Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs: an analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839-46
34. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-hepatic injuries: a French population-based study. Hepatology 2002; 36: 451-5
35. Miller MA. Gender-based differences in the toxicity of pharmaceuticals: Food and Drug Administration's perspective. Int J Toxicol 2001; 20: 149-52
36. Weis KH. Haemaccel 35: adverse reactions in a multicentric, prospective study. Anaesthesist 1983; 32: 488-93
37. Lorenz W, Duda D, Dick W, et al. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Trial Group Mainz/Marburg. Lancet 1994; 343: 933-40
38. Celik I, Duda D, Stinner B, et al. Early and late histamine release induced by albumin, hetastarch and polygeline: some unexpected findings. Inflamm Res 2003; 52: 408-16
39. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; I: 466-9
40. Koch C. Blood, blood components, plasma and plasma products. In: Dukes MNG, Aronson JK, editors. Meyler's side effects of drugs. 14th ed. Amsterdam: Elsevier, 2000: 1111-39
41. Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621-8
42. Thomsen HS, Bush WH. Adverse effects of contrast media: incidence, prevention and management. Drug Saf 1998; 19: 313-24
43. Maddox TG. Adverse reactions to contrast material: recognition, prevention, and treatment. Am Fam Physician 2002; 66: 1229-34
44. Zuckerman GB, Riess PL, Patel L, et al. Development of a life-threatening anaphylactoid reaction following administration of ioversol in a child. Pediatr Radiol 1999; 29: 295-7
45. Alvarez Fernandez JA, Valero AM, Pulido Z, et al. Hypersensitivity reaction to ioversol. Allergy 2000; 55: 581-2
46. Dewachter P, Mouton-Faivre C, Felden F. Allergy and contrast media. Allergy 2001; 56: 250-1
47. Nakamura I, Hori S, Funabiki T, et al. Cardiopulmonary arrest induced by anaphylactoid reaction with contrast media. Resuscitation 2002; 53: 223-6
48. Ketkar M, Shrier D. An allergic reaction to intraarterial non-ionic contrast material [letter]. AJNR Am J Neuroradiol 2003; 24: 292
49. Laroche D, Aimone-Gastin I, Dubois F, et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 1998; 209: 183-90
50. Laroche D, Namour F, Lefrancois C, et al. Anaphylactoid and anaphylactic reactions to iodinated contrast material. Allergy 1999; 54 Suppl. 58: 13-6
51. Lasser EC. The multipotential pseudoantigenicity of X-ray contrast media: pseudoantigen excess may downregulate the release of hypotensive mediators. Int Arch Allergy Immunol 2000; 123: 282-90
52. Lasser EC. The radiocontrast molecule in anaphylaxis: a surprising antigen. Novartis Found Symp 2004; 257: 211-24
53. Bartlett MJ, Bynevelt M. Acute contrast reaction management by radiologists: a local audit study. Australas Radiol 2003; 47: 363-7
54. Ministero della Salute. Drug utilization in Italy. National report year 2003 [online]. Available from URL: http://www.ministerosalute.it/medicinali/ osmed/osmed.jsp [Accessed 2005 Apr 22]
55. Smythe MA, Cappelletty DM. Anaphylactoid reaction to levofloxacin. Pharmacotherapy 2000; 20: 1520-3
56. Ho D, Song J, Wang C. Anaphylactoid reaction to ciprofloxacin. Ann Pharmacother 2003; 37: 1018-23
57. Cinobac® product information. Corona (CA): Oclassen Pharmaceuticals, Inc., a division of Watson Labs, Inc., 1999 Jun 23
58. Stricker BH, Slagboom G, Demaeseneer R, et al. Anaphylactic reactions to cinoxacin. BMJ 1988; 297: 1434-5
59. Quercia O, Pafanelli S, Emiliani F, et al. Anaphylactic reaction to cinoxacin: report of one case associated with inferior acute myocardial infarction. Allerg Immunol (Paris) 2003; 35: 61-3
60. Polk RE. Alaphylactoid reactions to glycopeptide antibiotics. J Antimicrob Chemother 1991; 27 Suppl. B: 17-29
61. Perrett CM, McBride SR. Teicoplanin induced drug hypersensitivity syndrome. BMJ 2004; 328: 1292
62. Dux S, Groslop I, Garty M, et al. Anaphylactic shock induced by diclofenac. Brit Med J (Clin Res Ed) 1983; 286: 1861
63. Alkhawajah AM, Eifawal M, Mahmoud SF. Fatal anaphylactic reaction to diclofenac. Forensic Sci Int 1993; 60: 107-10
64. Schabitz WR, Berger C, Knauth M, et al. Hypoxic brain damage after intramuscular self-injection of diclofenac for acute back pain. Eur J Anaesth 2001; 18: 763-5
65. Sen I, Mitra S, Gombar KK. Fatal anaphylactic reaction to oral diclofenac sodium [letter]. Can J Anaesth 2001; 48: 421
66. Jonker MJ, Bruynzeel DP. Anaphylactic reaction elicited by patch testing with diclofenac. Contact Dermatitis 2003; 49: 114-5
67. Van der Klauw MM, Stricker BHCH, Herings RMC, et al. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993; 35: 400-8
68. Del Pozo MD, Lobera T, Blasco A. Selective hypersensitivity to diclofenac. Allergy 2000; 55: 412-3
69. 1 and IgE against co-injected TNP-OVA. Toxicol Lett 2002; 131: 167-80
70. Klasco RK, editor. DRUGDEX® System. Greenwood Village (CO): Thomson MICROMEDEX, 2004
71. Hernandez C, Aragones N, Estanyol N. Two cases of anaphylactic shock after metamizol given during postoperative recovery. Rev Esp Anestesiol Reanim 2004; 51: 168-9
72. Janke C, Schmeck J, Passami D, et al. Anaphylactic cardiocirculatory failure after intraoperative application od dipyrone. Anaesthesist 2003; 52: 321-5
73. Priima OB. The clinical picture and ambulatory treatment of drug-induced anaphylactic shock with a favourable course. Feldsher Akush 1991; 56: 33-5
74. Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003; 112: 815-20